Tumor markers after radiofrequency ablation therapy for hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 55, Issue 85, 2008, Pages 1454-1457

  Ogawa, Chikara ^a   Kudo, Masatoshi ^a   Minami, Yasunori ^a   Chung, Hobyung ^a   Kawasaki, Toshihiko ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Agglutinin reactive alpha fetoprotein; Alpha tetoprotein; Des gamma carboxy prothrombin; Hepatocellular carcinoma; Lens culinaris; Radiofrequency ablation therapy

Indexed keywords

AFP PROTEIN, HUMAN; ALPHA FETOPROTEIN; BIOLOGICAL MARKER; DECARBOXYPROTHROMBIN; PROTEIN PRECURSOR; PROTHROMBIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD; CATHETER ABLATION; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; REPRODUCIBILITY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; PROTHROMBIN; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 58149391838     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Taketa K, Endo Y, Sekiya C, Tanikawa K, Koji T, Taga H, Satomura S, et al.: A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res 1993; 53:5419-5423. (Pubitemid 23342160)
2. Sato Y, Nakata K, Kato Y, Shima M, Ishii N, Koji T, Taketa K, et al.: Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 1993; 328:1802-1806. (Pubitemid 23174710)
3. Khien VV, Mao HV, Chinh TT, Ha PT, Bang MH, Lac BV, Hop TV, et al.: Clinical evaluation of lectin-reactive alfa-fetoprotein-L3 in histology-proven hepatocellular carcinoma. Int J Biol Markers 2001; 16:105-111. (Pubitemid 32755127)
4. Yamashita F, Tanaka M, Satomura S, Tanikawa K: Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinoma. Gastroenterology 1996; 111:996-1001. (Pubitemid 26327602)
5. Aoyagi Y, Isokawa O, Suda T, Watanabe M, Suzuki Y, Asakura H: The fucosylation index of alpha-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma. Cancer 1998; 83:2076-2082. (Pubitemid 28525388)
6. Hayashi K, Kumada T, Nakano S, Takeda I, Sugiyama K, Kuriyama S, Sone Y, et al.: Usefulness of measurement of Lens culinaris agglutinin-reactive fraction alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma. Am J Gastroenterol 1999; 94:3028-3033. (Pubitemid 29482777)
7. Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Yamamoto M, Takaki K, et al.: Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alfa-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone. J Gastroenterol Hepatol 2002; 17:772-778. (Pubitemid 34779738)
8. Oka H, Saito A, Ito K, Kumada T, Satomura S, Kasugai H, Osaki Y, et al.: Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein. J Gastroenterol Hepatol 2001; 16:1378-1783.
9. Yoshida S, Kurokohchi K, Arima K, Masaki T, Hosomi N, Funaki T, Murota M, et al.: Clinical significance of Lens culinaris agglutinin-reactive fraction of serum α-fetoprotein in patients with hepatocellular carcinoma. Int J Oncol 2002; 20:305-309.
10. Okuda K, Tanaka M, Kanazawa N, Nagashima J, Satomura S, Kinoshita H, Eriguchi N, et al.: Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by Lens culinaris agglutinin-reactive α-fetoprotein. Int J Oncol 1999; 14:265-271.
11. Pugh RNH, Murray Lyon IN, Dawson JL, Pietroni M, Williams R: Transection of the oesophageus for bleeding esophageal varices. Br J Surg 1973; 60:646-649.
12. Liver Cancer Study Group of Japan: The general rules for the clinical and pathological study of primary liver cancer. 4th Edition. Kanehara, Tokyo 2000; p. 19. (In Japanese)
13. Kudo M, Chung H, Osaki Y: Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 2003; 38:207-15. (Pubitemid 36527122)
14. Burditt L, Johnson M, Johnson P, Williams R: Detection of hepatocellular carcinoma-specific alpha-fetoprotein by isoelectric focusing. Cancer 1994; 74:25-29. (Pubitemid 24187605)
15. Taketa K, Sekiya C, Namiki M, Akamatsu K, Ohta Y, Endo Y, Kosaka K: Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterology 1990; 99:508-518. (Pubitemid 20219108)
16. Taketa K, Liu M, Taga H: Interaction of lectins with their ligand carbohydrate of alpha-fetoprotein: analysis by mixed-lectin affinity electrophoresis. Electrophoresis 1996; 17:483-488. (Pubitemid 26126785)
17. Sittenfeld A, Moreno E: A sensitive blotting system for detection of alpha-fetoprotein variants with monoclonal and polyclonal antibodies. J Immunol Methods 1998; 106:19-26.
18. Shimizu K, Taniichi T, Satomura S, Matsuura S, Taga H, Taketa K: Establishment of assay kits for determination of microheterogeneities of alpha-fetoprotein using lectin-affinity electrophoresis. Clin Chim Acta 1993; 214:3-12. (Pubitemid 23055363)
19. Kaplan EL and Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
20. Cox DR: Regression models and life-tables. JR Stat Soc B 1972; 34:184-220.
21. Sassa T, Kumada T, Nakano S, Uematsu T: Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1999; 11:1387-1392. (Pubitemid 30009344)